🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 hora
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/05/2019 75,01 76,17 75,01 75,88 +1,02% 1,55% 11.579.142
01/05/2019 75,09 76,08 74,84 75,11 +0,01% 1,65% 15.288.643
30/04/2019 74,01 75,29 72,52 75,11 +2,51% 3,74% 11.269.039
29/04/2019 73,08 73,65 72,98 73,26 +0,20% 0,91% 7.395.317
26/04/2019 73,13 73,46 72,61 73,12 +0,38% 1,17% 8.888.193
25/04/2019 71,16 73,30 71,05 72,84 +2,15% 3,16% 13.994.154
24/04/2019 71,31 71,67 70,59 71,31 +0,17% 1,51% 12.779.102
23/04/2019 70,32 71,80 70,04 71,18 +1,55% 2,51% 19.281.523
22/04/2019 69,81 70,43 69,41 70,10 +0,37% 1,46% 14.548.441
18/04/2019 70,11 70,66 68,92 69,84 -0,99% 2,48% 32.768.445
17/04/2019 74,06 74,06 70,37 70,53 -4,69% 4,99% 34.181.463
16/04/2019 75,60 75,66 73,87 74,01 -1,24% 2,36% 12.531.250
15/04/2019 75,68 75,85 74,88 74,93 -1,13% 1,29% 13.822.491
12/04/2019 76,35 76,76 75,67 75,79 -0,51% 1,42% 10.164.762
11/04/2019 77,22 77,22 75,75 76,18 -1,21% 1,90% 10.410.518
10/04/2019 77,16 77,60 76,96 77,12 +0,02% 0,83% 6.894.268
09/04/2019 76,88 77,27 76,58 77,10 -0,19% 0,89% 10.785.282
08/04/2019 77,25 77,54 76,67 77,24 -0,25% 1,12% 10.586.267
05/04/2019 78,22 78,40 77,40 77,43 -0,86% 1,28% 10.324.162
04/04/2019 79,21 79,39 77,49 78,10 -1,60% 2,40% 10.257.719
03/04/2019 79,46 79,83 78,96 79,37 -0,04% 1,09% 6.550.734
02/04/2019 79,64 79,89 79,10 79,40 -0,11% 0,98% 5.875.088
01/04/2019 79,90 80,01 79,14 79,48 +0,16% 1,09% 8.820.282
29/03/2019 79,20 79,48 78,92 79,36 +0,65% 0,71% 10.147.994
28/03/2019 79,00 79,10 78,42 78,85 +0,41% 0,87% 7.161.298
27/03/2019 79,12 79,26 78,06 78,52 -0,76% 1,51% 10.020.766
26/03/2019 78,97 79,65 78,79 79,12 +0,69% 1,09% 9.242.731
25/03/2019 78,31 78,96 78,17 78,58 +0,07% 1,01% 7.878.654
22/03/2019 79,11 79,63 78,26 78,52 -0,80% 1,72% 10.639.191
21/03/2019 78,34 79,36 78,10 79,15 +1,06% 1,61% 9.473.291